Evaluating and Improving Your Tobacco Cessation Efforts Using Data-driven Decision-making, co-hosted by SCLC and NBHN


60 Minutes

Webinar Speakers

Jason Satterfield, PhD

Academy Endowed Chair for Innovation in Teaching and Professor of Clinical Medicine at the University of California, San Francisco

Jason M. Satterfield, PhD is the Academy Endowed Chair for Innovation in Teaching and Professor of Clinical Medicine in the Division of General Internal Medicine at the University of California San Francisco. He received his Bachelor of Science in brain sciences from MIT and his Ph.D. in clinical psychology from the University of Pennsylvania. Dr. Satterfield’s current interests include the integration of behavioral science in medical education, dissemination and implementation of evidence-based behavioral practices in primary care, and emerging mobile health technologies for behavioral health with a particular focus on smoking and substance use disorders. His current projects include training and implementation of medication-assisted treatment for opioid use disorders, the development and administration of the National Center for Tobacco Free Recovery, screening and brief interventions for substance misuse and tobacco, and the integration of social and behavioral sciences in medical, nursing, and social work curricula.

Webinar Objectives
  • Explain how to use results from comprehensive assessments to help tailor services

  • Determine how to use data to drive and support systems change

  • Describe how to enhance your tobacco cessation program using design thinking and a person-centered approach

Instructions for CME/CEU Credit

CME/CEUs are available for the recorded version of this webinar. Scroll down and click on the "Get Credit" button to begin.



This UCSF CME activity was planned and developed to uphold academic standards to ensure balance, independence, objectivity, and scientific rigor; adhere to requirements to protect health information under the Health Insurance Portability and Accountability Act of 1996 (HIPAA); and include a mechanism to inform learners when unapproved or unlabeled uses of therapeutic products or agents are discussed or referenced.

The following speakers, moderators and planning committee members have disclosed they have no financial interest/arrangement or affiliation with any commercial companies who have provided products or services relating to their presentation(s) or commercial support for this continuing medical education activity:

Christine Cheng, Dana Lange, Margaret Jaco Manecke, MSSW, Jennifer Matekuare, Jason M. Satterfield, PhD, Catherine Saucedo, Samara Tahmid, and Taslim van Hattum, LCSW, MPH and Steve Schroeder, MD